Skip to main content

Medication and glycemic control

Journal articles and book chapters

05-25-2018 | Diabetes self-management | Article

Type 1 diabetes self-management from emerging adulthood through older adulthood

McCarthy MM, Grey M. Diabetes Care 2018. doi: 10.2337/dc17-2597

Stethoscope on computer keyboard

05-24-2018 | Devices and technology | Review | Article

Telemedicine in complex diabetes management

McDonnell ME. Curr Diab Rep 2018; 18: 42. doi: 10.1007/s11892-018-1015-3

05-23-2018 | Insulin | Review | Article

Multinational consensus: Insulin initiation with insulin degludec/aspart (IDegAsp)

Kalra S et al. Adv Ther 2018; 35: 928–936. doi: 10.1007/s12325-018-0712-2

05-22-2018 | Cardiovascular disorders | Article

Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes

Matsutani D et al. Cardiovasc Diabetol 2018; 17: 73. doi: 10.1186/s12933-018-0717-9

05-22-2018 | Insulin | Article

Perceptions of insulin use in type 2 diabetes in primary care: A thematic synthesis

Ellis K, Mulnier H, Forbes A. BMC Fam Pract 2018; 19: 70. doi: 10.1186/s12875-018-0753-2

05-19-2018 | Liraglutide (T2DM) | Article

Retrospective analysis of an insulin-to-liraglutide switch in patients with type 2 diabetes mellitus

Introduction: Insulin and the GLP-1 receptor agonist liraglutide are both effective in reaching glycemic targets. The efficacy of an insulin-to-liraglutide switch in an obese population with concurrent use of sulfonylurea and metformin is unknown. We assessed the efficacy and determinants of success of an insulin-to-liraglutide switch in these patients.

05-18-2018 | Type 2 diabetes | Review | Article

Combination glucose-lowering therapy plans in T2DM: Case-based considerations

Blonde L, Dipp S, Cadena D. Adv Ther 2018. doi: 10.1007/s12325-018-0694-0

Person holding sweeteners

05-15-2018 | Diet | Article

Glycemic impact of non-nutritive sweeteners: A systematic review and meta-analysis of randomized controlled trials

Nichol AD, Holle MJ, An R. Eur J Clin Nutr 2018. doi: 10.1038/s41430-018-0170-6

05-10-2018 | Devices and technology | Review | Article

Diabetes care in the digital era: A synoptic overview

Fatehi F, Menon A, Bird D. Curr Diab Rep 2018; 18: 38. doi: 10.1007/s11892-018-1013-5

05-08-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: Do oral agents have a place?

Corcoy R et al. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.015

05-08-2018 | Mental health | Article

The effectiveness of stress management training on blood glucose control in patients with type 2 diabetes

Zamani-Alavijeh F et al. Diabetol Metab Syndr 2018; 10: 39. doi: 10.1186/s13098-018-0342-5

05-05-2018 | Physical activity | Review | Article

May the force be with you: Why resistance training is essential for subjects with type 2 diabetes mellitus without complications

Codella R et al. Endocrine 2018; Advance online publication. doi: 10.1007/s12020-018-1603-7

05-04-2018 | Insulin pumps | Article

Prevalence and geographical distribution of insulin pump therapy in the central Denmark region and its association with metabolic parameters

Kampmann U et al. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.042

05-03-2018 | Pregnancy | Review | Article

Pharmacotherapy for hyperglycemia in pregnancy: The new insulins

Toledano Y, Hadar E, Hod M. Diabetes Res Clin Prac 2018; Advance online publication. doi: 10.1016/j.diabres.2018.04.035

05-02-2018 | Type 2 diabetes | Article

General practitioners’ attitudes towards patients with poorly controlled type 2 diabetes: A qualitative study

Wollny A et al. BMC Fam Pract 2018; 19: 49. doi: 10.1186/s12875-018-0751-4

04-23-2018 | Gestational diabetes | Article

Neonatal hypoglycemia following diet-controlled and insulin-treated gestational diabetes mellitus

Voormolen et al. Diabetes Care 2018. doi: 10.2337/dc18-0048

04-19-2018 | Type 2 diabetes | Article

Treatment intensification in type 2 diabetes: A real-world study of 2-OAD regimens, GLP-1 RAs, or basal insulin

Blonde L et al. Diabetes Ther 2018; Advance online publication. doi: 10.1007/s13300-018-0429-x